Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
2(11%)
Results Posted
43%(3 trials)
Terminated
2(11%)

Phase Distribution

Ph not_applicable
6
33%
Ph phase_3
5
28%
Ph phase_2
3
17%
Ph phase_1
2
11%

Phase Distribution

2

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
2(12.5%)
Phase 2Efficacy & side effects
3(18.8%)
Phase 3Large-scale testing
5(31.3%)
N/ANon-phased studies
6(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(3)
Completed(7)
Terminated(3)
Other(5)

Detailed Status

Completed7
unknown5
Recruiting2
Terminated2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
77.8%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (12.5%)
Phase 23 (18.8%)
Phase 35 (31.3%)
N/A6 (37.5%)

Trials by Status

completed739%
recruiting211%
unknown528%
withdrawn16%
not_yet_recruiting16%
terminated211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07365709Not Applicable

Liver Cirrhosis Complicated by Clinically Significant Portal Hypertension

Not Yet Recruiting
NCT07113808

Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China

Recruiting
NCT06497959Phase 3

Study of Placental Vascularization Using Contrast Ultrasound

Recruiting
NCT04146441Phase 2

Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma

Completed
NCT03477019Phase 1

Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer

Completed
NCT04920214

Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

Unknown
NCT04397640Not Applicable

Myocardial Contrast Echocardiography in Septic Patients

Unknown
NCT04294316Not Applicable

Enhanced-contrast Brain Ultrasound in Cardiorespiratory Arrest

Unknown
NCT03101176Not Applicable

Multiparametric Ultrasound Imaging in Prostate Cancer

Unknown
NCT03335566Phase 3

An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging

Completed
NCT00829413Phase 3

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Completed
NCT03290053Phase 3

Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)

Terminated
NCT03385200Phase 3

KVUS at Neoadjuvant CTx of Breast Cancer

Unknown
NCT01306292Phase 2

Safety of SonoVue on Pulmonary Hemodynamics

Completed
NCT01481441Not Applicable

Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer

Terminated
NCT00286559Phase 1

Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)

Withdrawn
NCT01815320Phase 2

CE-US in Renal Transplantation

Completed
NCT01765036Not Applicable

Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic Adenocarcinoma

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18